The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area

► Subjects with p53 Pro/Pro or MDM2 GG genotype significantly increased RCC risk. ► A significant multiplicative joint effect of p53 and p21 on RCC risk. ► RCC patients with p53 Arg/Arg genotype had efficient arsenic methylation capacity. ► Joint effect of p53 or MDM2 genotype and high urinary total arsenic on RCC risk.